Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
CHRS:NASDAQ
Coherus Oncology Inc
1,80 US$
+1,41%
(+0,025) 1D
1,81 US$
+0,55% (+0,0099)
After hours
Closed: 1 may, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHRS...
Açın
1,75 US$
High
1,80 US$
Low
1,73 US$
Mkt. cap
276,81 mln
Avg. vol.
1,26 mln
Volume
560,69K
52-wk high
2,62 US$
52-wk low
0,71 US$
EPS
-1,56 US$
Beta
1,03
Shares outstanding
154,22 mln
No. of employees
147
News stories
From sources across the web
About Coherus Oncology Inc
CEODennis Lanfear
Employees147
Founded2010
HeadquartersRedwood City, Kaliforniya, Amerika Birləşmiş Ştatları
Sector-
Websitecoherus.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
7,60 mln
10,25 mln
11,57 mln
12,75 mln
Cost of goods sold
2,65 mln
3,40 mln
3,72 mln
4,04 mln
Cost of revenue
2,65 mln
3,40 mln
3,72 mln
4,04 mln
Research and development expenses
24,36 mln
26,31 mln
27,25 mln
30,97 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,02 mln
26,04 mln
22,83 mln
21,01 mln
Operating expense
50,38 mln
52,34 mln
50,08 mln
51,98 mln
Total operating expenses
53,03 mln
55,74 mln
53,80 mln
56,03 mln
Operating income
-45,44 mln
-45,49 mln
-42,23 mln
-43,28 mln
Other non operating income
187,00K
2,90 mln
2,14 mln
-5,22 mln
EBT including unusual items
-47,40 mln
-44,86 mln
-44,52 mln
-46,35 mln
EBT excluding unusual items
-47,40 mln
-44,86 mln
-42,42 mln
-43,75 mln
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-56,57 mln
297,77 mln
-35,53 mln
-37,64 mln
Net profit margin
-744,43%
2.903,91%
-307,07%
-295,29%
Earnings per share
-0,35
-0,34
-0,33
-0,34
Interest and investment income
-
-
-
7,00 mln
Interest expense
-2,15 mln
-2,28 mln
-2,32 mln
-2,25 mln
Net interest expenses
-2,15 mln
-2,28 mln
-2,32 mln
4,75 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
-44,39 mln
-44,47 mln
-41,27 mln
-42,38 mln
Gain or loss from assets sale
-
-
-
-338,32 mln
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer